DGCRF Financials 07/16/2014 20:12:18 DiagnoCure I
Post# of 4
DiagnoCure Inc.
Period Ending Oct 31, 2013 Oct 31, 2012 Oct 31, 2011 Nov 01, 2010
Total Revenue 644 2,473 1,250 1,164
Cost of Revenue - - - -
Gross Profit 644 2,473 1,250 1,164
Operating Expenses
Research and Development 2,059 3,618 2,436 2,401
Sales, General and Admin. 2,067 2,614 2,613 2,225
Non-Recurring Items - - 718 225
Other - - - 1,454
Operating Income (3,482) (3,759) (4,516) (5,141)
Income From Continuing Operations
Add'l Income/Expense Items 66 92 62 14
Earnings Before Interest and Tax (3,416) (3,666) (4,454) (5,127)
Interest Expense 4 15 839 8
Earnings Before Tax (3,420) (3,681) (5,293) (5,134)
Income Tax - - - (248)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,420) (3,681) (5,293) (4,887)
Non Recurring Events
Discontinued Operations - - 4,020 (3,778)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,420) (3,681) (1,273) (8,665)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,420) (3,681) (1,273) (8,665)